These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6243714)

  • 21. Topical application of ethyl ether to recurrent herpes simplex.
    Takagaki K; Jidoi J
    J Dermatol; 1981 Apr; 8(2):109-11. PubMed ID: 7021621
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment of herpes labialis with topical acyclovir.
    Fiddian AP; Yeo JM; Stubbings R; Dean D
    Br Med J (Clin Res Ed); 1983 May; 286(6379):1699-701. PubMed ID: 6405939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.
    Kawashima M; Watanabe D; Fujio K; Komazaki H
    J Dermatol; 2023 Mar; 50(3):311-318. PubMed ID: 36353762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.
    Spruance SL; Crumpacker CS; Schnipper LE; Kern ER; Marlowe S; Arndt KA; Overall JC
    Antimicrob Agents Chemother; 1984 May; 25(5):553-5. PubMed ID: 6732224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes labialis treatment with acyclovir 5 per cent ointment.
    Raborn GW; McGaw WT; Grace M; Houle L
    J Can Dent Assoc; 1989 Feb; 55(2):135-7. PubMed ID: 2645030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis.
    Chen F; Xu H; Liu J; Cui Y; Luo X; Zhou Y; Chen Q; Jiang L
    J Oral Pathol Med; 2017 Sep; 46(8):561-568. PubMed ID: 27935123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ineffectiveness of topical ether for the treatment of genital herpes simplex virus infection.
    Corey L; Reeves WC; Chiang WT; Vontver LA; Remington M; Winter C; Holmes KK
    N Engl J Med; 1978 Aug; 299(5):237-9. PubMed ID: 351401
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections.
    Myers MG; Oxman MN; Clark JE; Arndt KA
    N Engl J Med; 1975 Nov; 293(19):945-9. PubMed ID: 170521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.
    Spruance SL; Freeman DJ; Stewart JC; McKeough MB; Wenerstrom LG; Krueger GG; Piepkorn MW; Stroop WG; Rowe NH
    J Infect Dis; 1991 Apr; 163(4):728-34. PubMed ID: 1849159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
    Van Vloten WA; Swart RN; Pot F
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():89-93. PubMed ID: 6355055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
    Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
    J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial.
    Shafran SD; Sacks SL; Aoki FY; Tyrrell DL; Schlech WF; Mendelson J; Rosenthal D; Gill MJ; Bader RL; Chang I
    J Infect Dis; 1997 Jul; 176(1):78-83. PubMed ID: 9207352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: case study.
    Zhao M; Jiang J; Zheng R; Pearl H; Dickinson D; Fu B; Hsu S
    Inflamm Allergy Drug Targets; 2012 Oct; 11(5):364-8. PubMed ID: 22583482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical double-blind trial of topical zinc sulfate for herpes labialis recidivans].
    Kneist W; Hempel B; Borelli S
    Arzneimittelforschung; 1995 May; 45(5):624-6. PubMed ID: 7612066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
    Morrel EM; Spruance SL; Goldberg DI;
    Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.